Nerve block showdown: which eases hip fracture surgery pain best?

NCT ID NCT07717463

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This trial compares two types of nerve blocks—the newer PENG block and the traditional femoral nerve block—given before spinal anesthesia for hip fracture surgery. The goal is to see which one better reduces pain and helps patients sit comfortably for the spinal injection. Adults aged 50 and older with hip fractures are being studied to find the most effective approach.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a nerve block procedure using bupivacaine
What this could lead to
If one nerve block proves better, it could make spinal anesthesia easier and less painful for people with hip fractures.
What could go wrong
This is a small, single-center trial, so results may not apply broadly. Both blocks carry risks like infection or nerve damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 50 years or older. * Diagnosis of proximal femoral fracture. * Scheduled to undergo surgical repair under spinal anesthesia. * American Society of Anesthesiologists (ASA) physical status I-III. * Able to provide written informed consent. Exclusion Criteria: * Refusal to participate or inability to provide informed consent. * Coagulopathy or contraindication to spinal anesthesia or peripheral nerve block. * Local infection at the planned injection site. * Known allergy or hypersensitivity to local anesthetics. * Pre-existing neurological disease affecting lower extremity function or sensory assessment. * Cognitive impairment preventing reliable study participation or outcome assessment. * Previous lumbar spine surgery. * Polytrauma. * Body mass index (BMI) \<18 kg/m² or \>40 kg/m². * Current anticoagulant therapy that precludes neuraxial anesthesia or peripheral nerve block according to institutional practice.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fractures are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taksim Training and Research Hospital

    NOT_YET_RECRUITING

    Istanbul, Beyoglu, Turkey (Türkiye)

  • Taksim Training and Research Hospital

    RECRUITING

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.